Accéder au contenu
Merck

Cardiovascular failure in mouse embryos deficient in VEGF receptor-3.

Science (New York, N.Y.) (1998-10-30)
D J Dumont, L Jussila, J Taipale, A Lymboussaki, T Mustonen, K Pajusola, M Breitman, K Alitalo
RÉSUMÉ

Vascular endothelial growth factor (VEGF) is a key regulator of blood vessel development in embryos and angiogenesis in adult tissues. Unlike VEGF, the related VEGF-C stimulates the growth of lymphatic vessels through its specific lymphatic endothelial receptor VEGFR-3. Here it is shown that targeted inactivation of the gene encoding VEGFR-3 resulted in defective blood vessel development in early mouse embryos. Vasculogenesis and angiogenesis occurred, but large vessels became abnormally organized with defective lumens, leading to fluid accumulation in the pericardial cavity and cardiovascular failure at embryonic day 9.5. Thus, VEGFR-3 has an essential role in the development of the embryonic cardiovascular system before the emergence of the lymphatic vessels.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
FLT4 (800-end), active, GST tagged human, PRECISIO® Kinase, recombinant, expressed in baculovirus infected Sf9 cells, ≥70% (SDS-PAGE), buffered aqueous glycerol solution